Montmorillonite-phosphatidyl choline/PDMS films: A novel antithrombogenic material

Applied Clay Science

Volumn 46, Issue 4, 2009, Pages 401-403

  Zhou, Ninglin ^a,b   Fang, Su ^a   Xu, Dong ^a   Zhang, Jun ^a,b   Mo, Hong ^a,b   Shen, Jian ^a,b  

^a NANJING NORMAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Blood compatibility; Composite; Intercalation; Montmorillonite; PDMS; Phosphatidyl choline

Indexed keywords

BLOOD COMPATIBILITY; COMPOSITE; MONTMORILLONITE; PDMS; PHOSPHATIDYL CHOLINE;

BLOOD; BLOOD SUBSTITUTES; CLAY MINERALS; COMPOSITE MICROMECHANICS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; MECHANICAL PROPERTIES; MICROCHANNELS; SILICATE MINERALS; X RAY DIFFRACTION;

SILICONES;

COMPOSITE; FTIR SPECTROSCOPY; MECHANICAL PROPERTY; MONTMORILLONITE; PHOSPHOLIPID; X-RAY DIFFRACTION;

EID: 70449519440     PISSN: 01691317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clay.2009.10.012     Document Type: Article

References (13)

1. Dong Y., and Feng S.S. Poly(D, L-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials 26 30 (2005) 6068-6076
2. Feng S.-S., Mei L., Anitha P., Gan C.W., and Zhou W. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Biomaterials 30 19 (2009) 3297-3306
3. Joshi G.V., Kevadiya B.D., Patel H.A., Bajaj H.C., and Jasra R.V. Montmorillonite as a drug delivery system: intercalation and in vitro release of timolol maleate. Int. J. Pharm. 374 1-2 (2009) 53-57
4. Kaneko M.L.Q.A., and Yoshida I.V.P. Effect of natural and organically modified montmorillonite clays on the properties of polydimethylsiloxane rubber. J. Appl. Polym. Sci. 108 4 (2008) 2587-2596
5. Lee Y., Kuo T., Chen B., Feng Y., Wen Y., and Lin W. Toxicity assessment of montmorillonite as a drug carrier for pharmaceutical applications: yeast and rats model. Biomed. Eng. Appl. Basis Commun. 17 2 (2005) 12-18
6. Li Y.-J., Hanada T., and Nakaya T. Surface modification of segmented polyurethanes by grafting methacrylates and phosphatidylcholine polar headgroups to improve hemocompatibility. Chem. Mater. 11 3 (1999) 763-770
7. Lin F.H., Lee Y.H., Jian C.H., Wong J.-M., Shieh M.-J., and Wang C.-Y. A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier. Biomaterials 23 9 (2002) 1981-1987
8. Nagendiran S., Premkumar S., and Alagar M. Mechanical and morphological properties of organic-inorganic, hybrid, clay-filled, and cyanate ester/siloxane toughened epoxy nanocomposites. J. Appl. Polym. Sci. 106 2 (2007) 1263-1273
9. Park J.K., Choy Y.B., Oh J.-M., Kim J.Y., Hwang S.-J., and Choy J.-H. Controlled release of donepezil intercalated in smectite clays. Int. J. Pharm. 359 1-2 (2008) 198-204
10. Sanchez-Verdejo T., Undabeytia T., Nir S., Maqueda C., and Morillo E. Environmentally friendly slow release formulations of alachlor based on clay-phosphatidylcholine. Environ. Sci. Technol. 42 15 (2008) 5779-5784
11. Tomita T., Li Y.-J., and Nakaya T. Grafting 2-(Methacryloyloxy)ethyl-2-(trimethylammonium)ethyl phosphate onto segmented polyurethane surfaces to improve hemocompatibilities. Chem. Mater. 11 8 (1999) 2155-2162
12. Wang X., Du Y., and Luo J. Biopolymer/montmorillonite nanocomposite: preparation, drug-controlled release property and cytotoxicity. Nanotechnology 19 6 (2008) 065707/065701-065707/065707
13. Zheng J.P., Luan L., Wang H.Y., Xi L.F., and Yao K.D. Study on ibuprofen/montmorillonite intercalation composites as drug release system. Appl. Clay Sci. 36 4 (2007) 297-301